Hematologia Geral
Estimativas nacionais, regionais e globais de anemia conforme a gravidade em mulheres e crianças de 2000 a 2019.
21 Abr, 2022 | 12:09hComentário convidado: Sustainable Development Goals for anaemia: 20 years later, where are we now? – The Lancet Global Health
Estudo clínico fases 1-2 | Rilzabrutinibe, um inibidor BTK oral, na trombocitopenia imune.
21 Abr, 2022 | 11:21hRilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: Rilzabrutinib for blood disorder shows promise in phase 1–2 clinical trial – Massachusetts General Hospital
Comentário no Twitter
Rilzabrutinib had rapid and durable clinical activity in adults with immune thrombocytopenia, with low-level toxic effects. https://t.co/boWT4LpQkk pic.twitter.com/ZpNXHYL2Gv
— NEJM (@NEJM) April 18, 2022
Estudo randomizado | Mitapivate vs. placebo para deficiência de piruvatoquinase.
19 Abr, 2022 | 12:31hMitapivat versus Placebo for Pyruvate Kinase Deficiency – New England Journal of Medicine
Estudo de coorte | Tipo sanguíneo não O está associado a risco aumentado de tromboembolismo venoso em pacientes com câncer.
18 Abr, 2022 | 15:19hABO blood group type and risk of venous thromboembolism in patients with cancer – Blood Advances (link para o resumo – $ para o texto completo)
Revisão | Manifestações cutâneas da gamopatia monoclonal.
18 Abr, 2022 | 15:13hCutaneous manifestations of monoclonal gammopathy – Blood Cancer Journal
M-A | Padrões de trombose e desfecho clínico da trombocitopenia trombótica imune induzida por vacina contra COVID-19.
11 Abr, 2022 | 12:58hConteúdos relacionados:
Case series of Thrombosis with Thrombocytopenia Syndrome after Covid-19 vaccination in the US.
Review: Vaccine-induced immune thrombotic thrombocytopenia.
Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
Clinical features of vaccine-induced immune thrombocytopenia and thrombosis.
Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.
Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (vários artigos e fontes sobre o tema)
Estudo mostra risco aumentado de embolia pulmonar em até 110 dias após a COVID-19.
8 Abr, 2022 | 21:58hComunicado de imprensa: Study finds increased risk of serious blood clots up to six months after COVID-19 – BMJ
Editorial: Thromboembolism and bleeding after covid-19
Comentário: Covid: Blood clot risk higher for six months after having virus – BBC
M-A | Risco de recorrência em mulheres com tromboembolismo venoso relacionado ao uso de contraceptivos com estrogênio.
8 Abr, 2022 | 17:28hEstudo randomizado | Eritropoietina não é benéfica para pacientes com lesão renal aguda.
8 Abr, 2022 | 17:02hErythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial – BMC Nephrology